Literature DB >> 1910811

Mesothelial cells produce a chemoattractant for lung fibroblasts: role of fibronectin.

M Kuwahara1, M Kuwahara1, K E Bijwaard, D M Gersten, C A Diglio, E Kagan.   

Abstract

Pleural fibrosis may complicate several types of non-exudative pleural injury. Although the pathogenesis of such lesions is poorly understood, it is conceivable that mesothelial cells may recruit fibroblasts to sites of pleural damage. In order to test this possibility, conditioned medium from cultured rat mesothelial cells was tested for chemoattractant activity towards RL-87 rat lung fibroblasts. For this purpose, rat pleural or pericardial mesothelial cells were maintained in vitro for 6 to 96 h. Conditioned medium from each source was obtained at defined culture times and tested for chemotactic activity in a 48-well microchemotaxis assembly. A progressive, time-dependent increase in fibroblast chemoattractant activity was detected in both pleural and pericardial mesothelial cell conditioned medium samples. This effect was maximal in 96-h cultures. Checkerboard analysis revealed that the conditioned medium was truly chemotactic for lung fibroblasts. Characterization of the chemoattractant demonstrated that it was a nondialyzable (greater than 16 kD), thermolabile (100 degrees C for 15 min), acid-stable (pH 2.5), trypsin-sensitive, and pepsin-sensitive protein. The chemotaxin was shown to be fibronectin, since activity was abolished, in a dose-dependent manner, by treatment with anti-rat fibronectin antiserum as well as by passage through a gelatin agarose affinity column. This product consisted of two bands on sodium dodecyl sulfate polyacrylamide gel electrophoresis of apparent molecular masses 250 and 220 kD. The secretion of a mesothelial cell-derived fibroblast chemoattractant may play a role in the response of the pleura to injury and in the pathogenesis of pleural fibrosis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1910811     DOI: 10.1165/ajrcmb/5.3.256

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  6 in total

Review 1.  The mesothelial cell and its role in asbestos-induced pleural injury.

Authors:  M Kuwahara; E Kagan
Journal:  Int J Exp Pathol       Date:  1995-06       Impact factor: 1.925

2.  Role of mesothelial and submesothelial stromal cells in matrix remodeling following pleural injury.

Authors:  R M Davila; E C Crouch
Journal:  Am J Pathol       Date:  1993-02       Impact factor: 4.307

3.  Cellular sources of transforming growth factor-beta isoforms in early and chronic radiation enteropathy.

Authors:  J Wang; H Zheng; C C Sung; K K Richter; M Hauer-Jensen
Journal:  Am J Pathol       Date:  1998-11       Impact factor: 4.307

4.  Metformin reduces pleural fibroelastosis by inhibition of extracellular matrix production induced by CD90-positive myofibroblasts.

Authors:  Yoichiro Aoshima; Yasunori Enomoto; Atsuki Fukada; Yuki Kurita; Sayomi Matsushima; Shiori Meguro; Isao Kosugi; Hideya Kawasaki; Hiroaki Katsura; Tomoyuki Fujisawa; Noriyuki Enomoto; Yutaro Nakamura; Naoki Inui; Takafumi Suda; Toshihide Iwashita
Journal:  Am J Transl Res       Date:  2021-11-15       Impact factor: 4.060

5.  Role of talc modulation on cytokine activation in cancer patients undergoing pleurodesis.

Authors:  Yehuda Schwarz; Alex Star
Journal:  Pulm Med       Date:  2012-03-07

6.  Role of [Ca(2+)]i and F-actin on mesothelial barrier function.

Authors:  Masayoshi Kuwahara
Journal:  Front Physiol       Date:  2014-06-30       Impact factor: 4.566

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.